KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Gains from Investment Securities (2016 - 2025)

Medpace Holdings (MEDP) has disclosed Gains from Investment Securities for 10 consecutive years, with $1.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Gains from Investment Securities fell 98.71% year-over-year to $1.0 million, compared with a TTM value of $92.6 million through Dec 2025, up 10.87%, and an annual FY2025 reading of $875000.0, down 98.95% over the prior year.
  • Gains from Investment Securities was $1.0 million for Q4 2025 at Medpace Holdings, up from -$53000.0 in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $79.7 million in Q4 2024 and bottomed at -$8.0 million in Q1 2024.
  • Average Gains from Investment Securities over 4 years is $6.5 million, with a median of $147294.0 recorded in 2021.
  • Peak annual rise in Gains from Investment Securities hit 29231.71% in 2024, while the deepest fall reached 80170.0% in 2024.
  • Year by year, Gains from Investment Securities stood at $3.3 million in 2021, then crashed by 160.16% to -$2.0 million in 2023, then surged by 4108.6% to $79.7 million in 2024, then tumbled by 98.71% to $1.0 million in 2025.
  • Business Quant data shows Gains from Investment Securities for MEDP at $1.0 million in Q4 2025, -$53000.0 in Q3 2025, and $79.7 million in Q4 2024.